Skip to main content
SpringerLink
Log in

Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and Management

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Although first described about 100yr ago, atrial fibrillation (AF) is now recognized as the most common of all arrhythmias. It has a substantial morbidity and presents a considerable health care burden. Improved diagnosis and an ageing population with an increased likelihood of underlying cardiac disease results in AF in more than 1% of population. AF is associated with an approximately two-fold increase in mortality, largely due to stroke which occurs at an annual rate of 5–7%. Another risk to survival is heart failure, which is aggravated by poor control of the ventricular rate during AF. Usually AF is associated with a variety of symptoms: palpitations, dyspnea, chest discomfort, fatigue, dizziness, and syncope. Paroxysmal AF is likely to be symptomatic and frequently presents with specific symptoms, while permanent AF is usually associated with less specific symptoms. However, in at least one third of patients, no obvious symptoms or noticeable degradation of quality of life are observed. This asymptomatic, or silent, AF is diagnosed incidentally during routine physical examinations, pre-operative assessments or population surveys. Recently, a very large incidence of generally short paroxysms of AF has been seen in patients with implantable pacemakers or defibrillators and these arrhythmias are often silent. Pharmacological suppression of arrhythmia may be associated with a conversion from a symptomatic to an asymptomatic form of AF. Holter monitoring and transtelephonic monitoring studies have demonstrated that asymptomatic episodes of AF exceed symptomatic paroxysms by twelve-fold or more.

Although symptoms may not stem directly from AF, the risk of complications is probably the same for symptomatic and asymptomatic patients. AF is found incidentally in about 25% of admissions for a stroke. Studies in patients with little or no awareness of their arrhythmia condition indicate that unrecognized and untreated AF may cause congestive heart failure. In patients with coronary bypass, AF may not only represent risk for immediate postoperative morbidity and increase hospital resource utilization, but being unrecognized, may produce a significant impact on long-term survival and quality of life. Although silent AF merits consideration for anticoagulation and rate control therapy according to standard criteria, whether antiarrhythmic therapy is relevant in this condition remains unclear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lewis T. Auricular fibrillation: a common clinical condition. Br Med J 1909;2:1528.

    Google Scholar 

  2. Martin A, Benbow LJ, Butrous GS, Leach C, Camm AJ. Five year follow-up of 101 elderly subjects by means of long-term ambulatory cardiac monitoring. Eur Heart J 1984;5:592-596.

    Google Scholar 

  3. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-2461.

    Google Scholar 

  4. Campbell A, Caird FI, Jackson TFM. Prevalence of electrocardiogram in old people. Br Heart J 1974;36: 1005-1011.

    Google Scholar 

  5. Mihalik MJ, Fisch G. Electrocardiographic findings in the aged. Am Heart J 1974;87:117-128.

    Google Scholar 

  6. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306: 1018-1022.

    Google Scholar 

  7. Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 1995;98:476-484.

    Google Scholar 

  8. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol 1988;61:714-717.

    Google Scholar 

  9. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. Arch Intern Med 1987;147:1561-1564.

    Google Scholar 

  10. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.

    Google Scholar 

  11. Zipes DP. Atrial fibrillation. A tachycardia-induced atrial cardiomyopathy. Circulation 1997;95:562-564.

    Google Scholar 

  12. Defaye P, Dournaux F, Mouton E, for the Aida Multicenter Study Group. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. PACE 1998;21:250-255.

    Google Scholar 

  13. Garrigue S, Cazeau S, Ritter P, Lazarus A, Gras D, Mugica J. [Incidence of atrial arrhythmias in patients with dual-chamber pacemakers: value of the pacemaker Holter function] [French]. Arch Mal Coeur Vas 1996;89:873-881.

    Google Scholar 

  14. Levy S, Rodriguez LM, Camm AJ, Thibault B, Jordaens L, Rosenqvist M, Seidl KH, Wellens HJJ, for the Metrix Investigators. Number, duration and frequency of non-treated atrial fibrillation episodes observed during the Metrix Automatic Implantable Atrial Defibrillator Trial. PACE 1998;21: 811(abstr).

    Google Scholar 

  15. Kerr C, Boone J, Connolly S, Greene M, Klein G, Sheldon R, Talajic M. Follow-up of atrial fibrillation: the initial experience of the Canadian Registry of Atrial Fibrillation. Eur Heart J 1996;17(Suppl C): 48-51.

    Google Scholar 

  16. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA 1985;254:3449-3453.

    Google Scholar 

  17. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987;317: 669-674.

    Google Scholar 

  18. Ciaroni S, Bloch A. [Mid-term clinical and prognostic evaluation of idiopathic atrial fibrillation] [French]. Arch Mal Coeur Vas 1993;86:1025-1030.

    Google Scholar 

  19. Camm AJ, Evans KE, Ward DE, Martin A. The rhythm of the heart in active elderly subjects. Am J Cardiol 1980;99:598-603.

    Google Scholar 

  20. Molaschi M, Ponzetto M, Romin R, Berrino E, Fabris F. [Changes in the electrocardiogram in the elderly patient: the limits between normality and pathology] [Ital]. Recenti Progressi in Medicina 1995;86:32-36.

    Google Scholar 

  21. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM, for the CHS Collaborative Research Group. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-241.

    Google Scholar 

  22. Lombardi F, Tozillo D, Cappiello E. Sympatho-vagal influence in atrial fibrillation. N Trends Arrhythmias 1993;9:179-184.

    Google Scholar 

  23. Dietz A, Walter J, Bracharz H, Bracharz M, Unkelbach S, Franke H. [Cardiac arrhythmias in active elderly persons-age dependence on heart rate and arrhythmias] [German]. Z Kardiol 1987;76:86-94.

    Google Scholar 

  24. Ramsdale DR, Arumugam N, Singh SS, Pearson J, Charles RG. Holter monitoring in patients with mitral stenosis and sinus rhythm. Eur Heart J 1987;8:164-170.

    Google Scholar 

  25. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett ELC. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-227.

    Google Scholar 

  26. Bhandari AK, Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Cullen MT, Hawkinson RW, Pritchett ELC, on behalf of the Flecainide Supraventricular Tachycardia Study Group. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. Am Heart J 1992;124:381-386.

    Google Scholar 

  27. Wolk R, Kulakowski P, Karczmarewicz S, Karpinski G, Makowska E, Czepiel A, Ceremuzynski L. The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone. Int J Cardiol 1996;54:207-211.

    Google Scholar 

  28. Frishman WH, Heiman M, Karpenos A, Ooi WL, Mitzner A, Goldkom R, Greenberg S. Twenty-four-hour ambulatory electrocardiography in elderly subjects: prevalence of various arrhythmias and prognostic implications (report from the Bronx Longitudinal Aging Study). Am Heart J 1996;132:297-302.

    Google Scholar 

  29. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A, on behalf of the College of French Cardiologists. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA Study. Circulation 1999;99:3028-3035.

    Google Scholar 

  30. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial Æbrillation in a population based cohort: the Framingham Heart Study. JAMA 1994;271:840-844.

    Google Scholar 

  31. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: the Framingham Study. Stroke 1983;14:664-667.

    Google Scholar 

  32. Lin H-J, Wolf PA, Benjamin EJ, Belanger AJ, D'Agostino RB. Newly diagnosed atrial fibrillation and acute stroke: the Framingham Study. Stroke 1995;26:1527-1530.

    Google Scholar 

  33. Ratcliffe PJ, Wilcock GK. Cerebrovascular disease in dementia: the importance of atrial fibrillation. Postgrad Med J 1985;61:201-204.

    Google Scholar 

  34. Kempster PA, Gerraty RP, Gates PC. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. Stroke 1988;19:955-957.

    Google Scholar 

  35. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, Thadani V, Meyer ML, Bridgers SL, for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. Circulation 1995;92: 2178-2182.

    Google Scholar 

  36. Kase CS, Wolf PA, Chodosh EH, Zacker HB, Kelly-Hayes M, Kannel WB, D'Agostino RB, Scampini L. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study. Stroke 1989;20: 850-852.

    Google Scholar 

  37. Feinberg WM, Seeger JF, Carmody RF, Anderson DC, Hart RG, Pearce LA. Asymptomatic cerebral infarction in patients with atrial fibrillation. Circulation 1988;19:955-957.

    Google Scholar 

  38. Petersen P, Pedersen F, Madsen EB, Brun B, Gyldensted C, Boysen G. Echocardiography and cerebral computed tomography in chronic atrial fibrillation. Eur Heart J 1989;10:1101-1104.

    Google Scholar 

  39. Cullinane M, Wainwright R, Brown A, Monaghan M, Markus HS. Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study. Stroke 1998;29:1810-1815.

    Google Scholar 

  40. Farina E, Magni E, Ambrosisni F, Manfredini R, Binda A, Sina C, Mariani C. Neurophysiological deficits in asymptomatic atrial fibrillation. Acta Neurol Scand 1997;96:310-316.

    Google Scholar 

  41. Ott A, Breteler MM, De Bruyne MC, Van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study: the Rotterdam Study. Stroke 1997;28:316-321.

    Google Scholar 

  42. Lavy S, Stern S, Melamed E, Cooper G, Keren A, Levy P. Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke 1980;11:35-38.

    Google Scholar 

  43. Brill IC. Auricular fibrillation with congestive failure and no other evidence of organic heart disease. Am Heart J 1937;13:175-182.

    Google Scholar 

  44. Phillips E, Levine SA. Auricular fibrillation without other evidence of heart disease: a cause of reversible heart failure. Am J Med 1949;7:478-489.

    Google Scholar 

  45. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients. Circulation 1991;84:40-48.

    Google Scholar 

  46. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1570-573.

    Google Scholar 

  47. Peters KG, Kienzle MG. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Cardiol 1988;85:242-244.

    Google Scholar 

  48. Van den Berg MP, Van Veldhuisen DJ, Crijns HJGM, Lie KI. Reversion of tachycardiomyopathy after ?-blocker. Lancet 1993;341:1667(letter).

    Google Scholar 

  49. Kieny JR, Sacrez A, Facello A, Arbogast R, Bareiss P, Roul G, Demangeat JL, Brunot B, Constantinesco A. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J 1992;13:1290-1295.

    Google Scholar 

  50. Van Gelder IC, Crijns HJ, Blanksma PK, Landsman MLJ, Posma JL, Van Den Berg MP, Meijler FL, Lie KI. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 1993;72:560-566.

    Google Scholar 

  51. Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman RE, Gallagher JJ, German LD. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol 1986;57: 563-570.

    Google Scholar 

  52. Rosenqvist M, Lee MA, Moulinier L, Springer MJ, Abbot JA, Wu J, Langberg JJ, Griffin JC, Scheinman MM. Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. J Am Coll Cardiol 1990;16:1467-1474.

    Google Scholar 

  53. Rodriguez LM, Smeets JL, Xie B, de Chillou C, Cheriex E, Pieters F, Metzger J, den Dulk K, Wellens HJJ. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 1993;72:1137-1141.

    Google Scholar 

  54. Geleen P, Goethals M, de Bruyne, Brugada P. A prospective hemodynamic evaluation of patients with chronic atrial fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction. Am J Cardiol 1997;80:1606-1609.

    Google Scholar 

  55. Fitzpatrick AP, Kourouyan HD, Siu A, Lee RJ, Lesh MD, Epstein LM, Griffin JC, Scheinman MM. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 1996;131:499-507.

    Google Scholar 

  56. Olsson SB, Carlson J, Holm M, Nilsson A. Atrioventricular nodal function in atrial fibrillation: what is the optimum ventricular rate? In: Murgantroyd FD, Camm AJ, eds. Nonpharmacological Management of Atrial Fibrillation. Armonk, NY: Futura Publishing, 1996:55-64.

    Google Scholar 

  57. Daoud EG, Weiss R, Bahu M, Knight BP, Bogun F, Goyal R, Harvey M, Strickberger SA, Man KC, Morady F. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996;78:1433-1436.

    Google Scholar 

  58. Natale A, Zimerman L, Tomassoni G, Kearney M, Kent V, Brandon MJ, Newby K. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 1996;78:1431-1433.

    Google Scholar 

  59. Cecchi F, Olivotto I, Montereggi A, Santoro A, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995;26:1529-1536.

    Google Scholar 

  60. Glancy DL, O'Brien KP, Gold HK, Epstein SE. Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J 1970;32:652-9.

    Google Scholar 

  61. Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990;15:1279-1285.

    Google Scholar 

  62. Brignole M, Gianfranchi L, Menozzi C, Bottoni N, Bollini R, Lolli G, Oddone D, Gaggioli G. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 1994;74:242-246.

    Google Scholar 

  63. Williamson BD, Man KC, Daoud E, Niebauer M, Strickberger SA, Morady F. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med 1994;331:910-917.

    Google Scholar 

  64. Marshall HJ, Harris ZI, Griffith MJ, Gammage MD. Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation. Heart 1998;79:543-547.

    Google Scholar 

  65. Morady F, Hasse C, Strickberger SA, Man KC, Daoud E, Bogun F, Goyal R, Harvey M, Knight BP, Weiss R, Bahu M. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 1997;27: 113-121.

    Google Scholar 

  66. Gianfranchi L, Brignole M, Menozzi C, Lolli G, Bottoni N. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dualchamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias. Am J Cardiol 1998;81:351-354.

    Google Scholar 

  67. Asher CR, Miller DP, Grimm RA, Cosgrove DM III, Chung MK. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol 1998;82:892-895.

    Google Scholar 

  68. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 1997;336:1429-1434.

    Google Scholar 

  69. Landymore RW, Howell F. Recurrent atrial arrhythmias following treatment for postoperative atrial fibrillation after coronary bypass operations. Eur J Cardiothorac Surg 1991;5:436-439.

    Google Scholar 

  70. Rose G, Baxter PJ, Reid DD, McCartney P. Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J 1978;40:636-643.

    Google Scholar 

  71. Kulbertus HE, de Leval-Rutten F, Bartsch P, Petit JM. Atrial fibrillation in elderly, anbulatory patients. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrial fibrillation. Mölndal: AB Hässle, 1982:148-157.

    Google Scholar 

  72. Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. JAMA 1981;245:1540-1544.

    Google Scholar 

  73. Howes CJ, Brandt C, Yerkey MW, Ruo B, Reid C, Ezekowitz MD. Quality of life and exercise tolerance in elderly, ambulatory patients with chronic atrial fibrillation. Circulation 1998;98(Suppl):I-703-I-704 (abstr).

    Google Scholar 

  74. Paquette M, Roy D, Talajic M, Newman D, Dorian P, for the CTAF Investigators. Sinus rhythm at the time of assessment is associated with better quality of life than atrial fibrillation or flutter results from the Canadian Trial of Atrial Fibrillation. PACE 1999;22: 863(abstr).

    Google Scholar 

  75. Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Cheng JJ, Ding YA, Chang MS. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 1998;31:637-644.

    Google Scholar 

  76. Woeber KA. Subclinical thyroid dysfunction. Arc Intern Med 1997;157:1065-1068.

    Google Scholar 

  77. Krahn AD, Klein GJ, Kerr CR, Boone J, Sheldon R, Green M, Talajic M, Wang X, Connolly S, for the Canadian Registry of Atrial Fibrillation Investigators. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? Arch Intern Med 1996;156:2221-2224.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St George's Hospital Medical School, Cranmer Terrace, London, SW17 0RE

    Irina Savelieva & A. John Camm

Authors
  1. Irina Savelieva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. John Camm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Savelieva, I., Camm, A.J. Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and Management. J Interv Card Electrophysiol 4, 369–382 (2000). https://doi.org/10.1023/A:1009823001707

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009823001707

Search

Navigation